Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Pharmacology|November 28, 1996
Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptorA Bergdahl, T Nilsson, L Cantera, et al.
Cardiovascular Drugs and Therapy|December 1, 1994
Efficacy and tolerability of felodipine ER and diltiazem SR as monotherapy in primary hypertension: a double-blind randomized studyT Thulin, H Almkvist, L Berglund, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1985
Monitoring 24-hour blood pressure in a drug trial. Evaluation of a noninvasive deviceG Berglund, U De Faire, J Castenfors, et al.
Intensive Care Medicine|March 25, 2015
Survival in patients without acute ST elevation after cardiac arrest and association with early coronary angiography: a post hoc analysis from the TTM trialJ Dankiewicz, N Nielsen, M Annborn, et al.
British Journal of Clinical Pharmacology|December 1, 1984
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patientsB Dahlöf, M Danielson, O Andersson, et al.
Molecular and Cellular Biochemistry|November 6, 2001
Endocardial expression and functional characterization of endothelin-1O Saetrum Opgaard, M Adner, T H Peters, et al.
Life Sciences|September 30, 1999
Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failureM Hou, M Malmsjö, S Möller, et al.
Acta Medica Scandinavica|January 1, 1984
A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensivesO R Nilsson, J H Atterhög, J Castenfors, et al.
Epidemiology and Psychiatric Sciences|June 6, 2017
Increased cardiovascular mortality in people with schizophrenia: a 24-year national register studyJ Westman, S V Eriksson, M Gissler, et al.
European Heart Journal. Acute Cardiovascular Care|October 24, 2018
Sex-related response to bivalirudin and unfractionated heparin in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A subgroup analysis of the VALIDATE-SWEDEHEART trialD Venetsanos, S Sederholm Lawesson, O Fröbert, et al.
Pageof 11